Retatrutide
US$ 22.71
novo nordisk glp-1 medications Details of failed studies cast pall on Nordisk's as Alzheimer's treatment Novo Nordisk, Hims & Hers
Description
Repost to share the impacts of these major GLP-1 price cuts
[DOI] [PubMed] [Google Scholar] 31.St-Pierre J., Klein J., Choi N.K., Fear E., Pannain S., Rubin D.T
[DOI] [PubMed] [Google Scholar] 50.Correll C.U., Lencz T., Malhotra A.K
While GLP-1 medications are meant for long-term use, this is not always feasible for every patient
At multivariate Cox regression analysis, diabetes duration (HR 1.08, 95% CI 1.021.14, P = 0.008) was the independent risk factor, and GLP-1 RAs therapy (HR 0.42, 95% CI: 0.200.88, P = 0.022) was the independent protective factor for the occurrence of MACEs in this population
